Skip to content

The association of serum IL-18 with cathecholamines and adverse cardiovascular events in the acute coronary syndrome patients: a prospective observational cohort study

The association of serum IL-18 with cathecholamines and adverse cardiovascular events in the acute coronary syndrome patients: a prospective observational cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-15005913
Enrollment
Unknown
Registered
2015-01-28
Start date
2015-02-09
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute coronary syndrome

Interventions

STEMI:no
NSTEMI:no
UAP:no

Sponsors

Peking university third hospital cadiology department
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.ST-Segment Elevation Myocardial Infarction (STEMI) group:(1)Age 18-80 years old; (2)Diagnosis of STEMI by the physicians on the basis of WHO criteria formulated in 1979; (3)Within 24 hours of symptom onset; (4)Written informed consent by the patient or surrogate. 2.Non ST-segment elevation myocardial infarction (NSTEMI) group:(1)Age 18-80 years old; (2)Clinical history of ischemic type chest pain lasting for more than 30 minutes;(3)Changes of serum cardiac biomarkers(CK-MB or troponin) (4)Changes in serial ECG tracings without ST-segment elevation Within 24 hours of symptom onset; (5)Written informed consent by the patient or surrogate 3. Unstable angina (UA) group:(1)Age 18-80 years old; (2)Ischemic chest pain occurring at rest or with minimal exertion, rapid deterioration of previously stable angina (crescendo pattern - more severe, prolonged or frequent than previously), or new onset severe ischemic chest pain of less than one month's duration; (4)Ischemic chest pain persists less than 30 minutes, ECG may be normal or may found ST-segment depression or T-wave inversion; (5)Serum cardiac biomarkers is normal Within 24 hours of symptom onset; (6)Written informed consent by the patient or surrogate.

Exclusion criteria

Exclusion criteria: (1)Valvular heart disease or other structural heart disease; (2)Known cardiomyopathy; (3)Prior surgery or trauma within 1 month prior to admission; (4)History of cerebrovascular disease in the past 6 months; (5)Malignancy; (6)Autoimmune disease; (7)Severe infection; (8)Severe hepatic or renal dysfunction.

Design outcomes

Primary

MeasureTime frame
epinephrine;norepinephrine;interleukin 18;

Countries

china

Contacts

Public ContactXiao Han
xiaohans98@163.com+86 13683088149

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026